title: Who should use recombinant factor VIII?
authors.affiliation: Gulf States Hemophilia Diagnostic and Treatment Center, University of Texas, Health Science Center, Houston 77030.
authors.forename: K
authors.initials: K
authors.lastname: Hoots
mesh_terms: D002648:Child; D005169:Factor VIII / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D015658:HIV Infections / Q000453:epidemiology*; D006679:HIV Seropositivity / Q000175:diagnosis / Q000453:epidemiology*; D006467:Hemophilia A / Q000188:drug therapy*; D006526:Hepatitis C / Q000453:epidemiology; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use*; D012307:Risk Factors
chemical_list: D011994:Recombinant Proteins; D005169:Factor VIII